Literature DB >> 18234266

Human T-cell leukemia virus type 1 blunts signaling by interferon alpha.

Xuan Feng1, Lee Ratner.   

Abstract

Although many animal viruses block the interferon (IFN) signaling pathway, this issue has not been previously investigated in retrovirus-infected cells. For this purpose, an infectious molecular clone of human T-cell leukemia virus type 1 (HTLV-1) was transfected into 293T or HeLa cells and was found to reduce interferon-stimulated response element (ISRE) reporter activity. This effect was independent of expression of the polymerase or envelope products and independent of the ability of Tax to activate the NFkappaB transcriptional pathway. IFN-alpha activation of 6 of 7 endogenous ISRE-regulated genes was also variably reduced, but not IFN-gamma-activated response element-mediated expression of interferon regulatory factor 1. HTLV-1 reduced the phosphorylation of tyrosine kinase 2 (TYK2) and signal transducer and transcriptional activator 2 (STAT2), suggesting a specific effect of HTLV-1 on the ability of an adaptor tyrosine kinase to transfer an IFN signal to the STAT-transcriptional activator complex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234266      PMCID: PMC2373983          DOI: 10.1016/j.virol.2007.12.036

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

Review 1.  Viruses and interferons.

Authors:  G C Sen
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

2.  Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy.

Authors:  T Furuya; T Nakamura; T Fujimoto; S Nakane; C Kambara; S Shirabe; S Hamasaki; M Motomura; K Eguchi
Journal:  J Neuroimmunol       Date:  1999-03-01       Impact factor: 3.478

3.  The HTLV receptor is a widely expressed protein.

Authors:  S R Trejo; L Ratner
Journal:  Virology       Date:  2000-03-01       Impact factor: 3.616

4.  West Nile virus inhibits the signal transduction pathway of alpha interferon.

Authors:  Ju-Tao Guo; Junpei Hayashi; Christoph Seeger
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression.

Authors:  P Kovarik; M Mangold; K Ramsauer; H Heidari; R Steinborn; A Zotter; D E Levy; M Müller; T Decker
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

6.  Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309.

Authors:  T Ruckes; D Saul; J Van Snick; O Hermine; R Grassmann
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

7.  Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone.

Authors:  M D Robek; L Ratner
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.

Authors:  S Li; S Labrecque; M C Gauzzi; A R Cuddihy; A H Wong; S Pellegrini; G J Matlashewski; A E Koromilas
Journal:  Oncogene       Date:  1999-10-14       Impact factor: 9.867

9.  Characterization of envelope glycoprotein mutants for human T-cell leukemia virus type 1 infectivity and immortalization.

Authors:  T Tsukahara; M M Wielgosz; L Ratner
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 10.  Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses.

Authors:  Adolfo García-Sastre
Journal:  Microbes Infect       Date:  2002-05       Impact factor: 2.700

View more
  16 in total

Review 1.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

2.  Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha.

Authors:  Ash A Alizadeh; Sean P Bohen; Chen Lossos; Jose A Martinez-Climent; Juan Carlos Ramos; Elena Cubedo-Gil; William J Harrington; Izidore S Lossos
Journal:  Leuk Lymphoma       Date:  2010-07

3.  Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.

Authors:  Claudio Fenizia; Martina Fiocchi; Kathryn Jones; Robyn Washington Parks; Michele Ceribelli; Sebastien A Chevalier; Dustin Edwards; Francis Ruscetti; Cynthia A Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

4.  Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1.

Authors:  Soratree Charoenthongtrakul; Qinjie Zhou; Noula Shembade; Nicole S Harhaj; Edward W Harhaj
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

Review 5.  Tumour viruses and innate immunity.

Authors:  Sharon E Hopcraft; Blossom Damania
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

6.  Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation.

Authors:  Anne Cachat; Sébastien Alain Chevalier; Sandrine Alais; Nga Ling Ko; Lee Ratner; Chloé Journo; Hélène Dutartre; Renaud Mahieux
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

7.  HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).

Authors:  Stéphanie Olière; Eduardo Hernandez; Agnès Lézin; Meztli Arguello; Renée Douville; Thi Lien-Anh Nguyen; Stéphane Olindo; Gérard Panelatti; Mirdad Kazanji; Peter Wilkinson; Rafick-Pierre Sékaly; Raymond Césaire; John Hiscott
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

8.  Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines.

Authors:  Britta Moens; Christophe Pannecouque; Giovanni López; Michael Talledo; Eduardo Gotuzzo; Ricardo Khouri; Achiléa Bittencourt; Lourdes Farré; Bernardo Galvão-Castro; Anne-Mieke Vandamme; Johan Van Weyenbergh
Journal:  Virol J       Date:  2012-08-23       Impact factor: 4.099

9.  The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases.

Authors:  Mari Kannagi; Atsuhiko Hasegawa; Ayako Takamori; Shuichi Kinpara; Atae Utsunomiya
Journal:  Front Microbiol       Date:  2012-09-03       Impact factor: 5.640

10.  Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells.

Authors:  Shuichi Kinpara; Mami Kijiyama; Ayako Takamori; Atsuhiko Hasegawa; Amane Sasada; Takao Masuda; Yuetsu Tanaka; Atae Utsunomiya; Mari Kannagi
Journal:  Retrovirology       Date:  2013-05-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.